Stocks and Investing Stocks and Investing
Wed, October 13, 2021
Tue, October 12, 2021
Mon, October 11, 2021
Sun, October 10, 2021
Fri, October 8, 2021
Thu, October 7, 2021

Akash Tewari Initiated (BNTX) at Hold and Held Target at $230 on, Oct 7th, 2021


Published on 2024-10-27 18:05:23 - WOPRAI, Akash Tewari
  Print publication without navigation


Akash Tewari of Jefferies, Initiated "BioNTech SE" (BNTX) at Hold and Held Target at $230 on, Oct 7th, 2021.

Akash has made no other calls on BNTX in the last 4 months.



There are 6 other peers that have a rating on BNTX. Out of the 6 peers that are also analyzing BNTX, 3 agree with Akash's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Daina Graybosch of "SVB Leerink" Maintained at Hold with Decreased Target to $268 on, Tuesday, October 5th, 2021
  • Eliana Merle of "UBS" Maintained at Hold with Increased Target to $300 on, Friday, August 27th, 2021
  • Robert Burns of "HC Wainwright & Co." Maintained at Hold with Increased Target to $330 on, Wednesday, August 11th, 2021


These are the ratings of the 3 analyists that currently disagree with Akash


  • Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $450 on, Friday, August 20th, 2021
  • Olga Smolentseva of "Bryan Garnier" Upgraded from Hold to Strong Buy and Held Target at $451 on, Wednesday, August 11th, 2021
  • Simon Baker of "Redburn Partners" Downgraded from Hold to Strong Sell on, Wednesday, June 16th, 2021